{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:12:07Z","timestamp":1780441927389,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC0565"],"award-info":[{"award-number":["2025ZNSFSC0565"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Science and Technology Project","doi-asserted-by":"crossref","award":["2024-YF05-02583-SN"],"award-info":[{"award-number":["2024-YF05-02583-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Radiation Oncology Key Laboratory of Sichuan Province Open Fund","award":["2023ROKF02"],"award-info":[{"award-number":["2023ROKF02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03907-7","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T14:45:24Z","timestamp":1752677124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of S1PR1 in VEGF-exosomes mediated resistance of hepatocellular carcinoma to anti-angiogenesis therapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Xinghong","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"3","key":"3907_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3907_CR2","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.2147\/JHC.S436962","volume":"10","author":"Z Li","year":"2023","unstructured":"Li Z, Zhang Z, Fang L, Zhao J, Niu Z, Chen H, Cao G. Tumor microenvironment composition and related therapy in hepatocellular carcinoma. J Hepatocell Carcinoma. 2023;10:2083\u201399.","journal-title":"J Hepatocell Carcinoma"},{"issue":"10","key":"3907_CR3","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/cac2.12195","volume":"41","author":"D Jiang","year":"2021","unstructured":"Jiang D, Zhang L, Liu W, Ding Y, Yin J, Ren R, Li Q, Chen Y, Shen J, Tan X, et al. Trends in cancer mortality in China from 2004 to 2018: A nationwide longitudinal study. Cancer Commun (Lond). 2021;41(10):1024\u201336.","journal-title":"Cancer Commun (Lond)"},{"key":"3907_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-030-37184-5_6","volume":"1234","author":"K Sobierajska","year":"2020","unstructured":"Sobierajska K, Ciszewski WM, Sacewicz-Hofman I, Niewiarowska J. Endothelial cells in the tumor microenvironment. Adv Exp Med Biol. 2020;1234:71\u201386.","journal-title":"Adv Exp Med Biol"},{"key":"3907_CR5","doi-asserted-by":"publisher","first-page":"1199225","DOI":"10.3389\/fphys.2023.1199225","volume":"14","author":"X Yao","year":"2023","unstructured":"Yao X, Zeng Y. Tumour associated endothelial cells: origin, characteristics and role in metastasis and anti-angiogenic resistance. Front Physiol. 2023;14:1199225.","journal-title":"Front Physiol"},{"key":"3907_CR6","doi-asserted-by":"publisher","first-page":"804983","DOI":"10.3389\/fonc.2022.804983","volume":"12","author":"AH Abdel Sater","year":"2022","unstructured":"Abdel Sater AH, Bouferraa Y, Amhaz G, Haibe Y, Lakkiss AE, Shamseddine A. From tumor cells to endothelium and gut microbiome: A complex interaction favoring the metastasis cascade. Front Oncol. 2022;12:804983.","journal-title":"Front Oncol"},{"issue":"1","key":"3907_CR7","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1038\/s41467-022-31981-2","volume":"13","author":"E Bae","year":"2022","unstructured":"Bae E, Huang P, M\u00fcller-Greven G, Hambardzumyan D, Sloan AE, Nowacki AS, Marko N, Carlin CR, Gladson CL. Integrin \u03b13\u03b21 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis. Nat Commun. 2022;13(1):4268.","journal-title":"Nat Commun"},{"issue":"1","key":"3907_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1189\/jlb.2RU0614-290R","volume":"97","author":"H Nomiyama","year":"2015","unstructured":"Nomiyama H, Yoshie O. Functional roles of evolutionary conserved motifs and residues in vertebrate chemokine receptors. J Leukoc Biol. 2015;97(1):39\u201347.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"3907_CR9","doi-asserted-by":"publisher","first-page":"a006536","DOI":"10.1101\/cshperspect.a006536","volume":"2","author":"AC Dudley","year":"2012","unstructured":"Dudley AC. Tumor endothelial cells. Cold Spring Harbor Perspect Med. 2012;2(3):a006536.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"3907_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3389\/fcell.2020.00755","volume":"8","author":"X Yao","year":"2020","unstructured":"Yao X, Xie L, Zeng Y. MiR-9 promotes angiogenesis via targeting on Sphingosine-1- phosphate receptor 1. Front Cell Dev Biol. 2020;8:755.","journal-title":"Front Cell Dev Biol"},{"issue":"17","key":"3907_CR11","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1038\/emboj.2012.183","volume":"31","author":"G Zhuang","year":"2012","unstructured":"Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 2012;31(17):3513\u201323.","journal-title":"EMBO J"},{"issue":"2","key":"3907_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"1","key":"3907_CR13","doi-asserted-by":"publisher","first-page":"1629865","DOI":"10.1080\/20013078.2019.1629865","volume":"8","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Yao X, Liu X, He X, Li L, Liu X, Yan Z, Wu J, Fu BM. Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracell Vesicles. 2019;8(1):1629865.","journal-title":"J Extracell Vesicles"},{"issue":"39","key":"3907_CR14","doi-asserted-by":"publisher","first-page":"63324","DOI":"10.18632\/oncotarget.11450","volume":"7","author":"Y Zeng","year":"2016","unstructured":"Zeng Y, Yao X, Chen L, Yan Z, Liu J, Zhang Y, Feng T, Wu J, Liu X. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7\/ syndecan-1\/TGF-\u03b2 autocrine loop. Oncotarget. 2016;7(39):63324\u201337.","journal-title":"Oncotarget"},{"key":"3907_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/164_2019_217","volume":"259","author":"M Maceyka","year":"2020","unstructured":"Maceyka M, Rohrbach T, Milstien S, Spiegel S. Role of sphingosine kinase 1 and sphingosine-1-Phosphate Axis in hepatocellular carcinoma. Handb Exp Pharmacol. 2020;259:3\u201317.","journal-title":"Handb Exp Pharmacol"},{"key":"3907_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jss.2020.11.044","volume":"259","author":"T Yokota","year":"2021","unstructured":"Yokota T, Nojima H, Kuboki S, Yoshitomi H, Furukawa K, Takayashiki T, Takano S, Ohtsuka M. Sphingosine-1-phosphate Receptor-1 promotes vascular invasion and EMT in hepatocellular carcinoma. J Surg Res. 2021;259:200\u201310.","journal-title":"J Surg Res"},{"issue":"6","key":"3907_CR17","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cellsig.2014.02.020","volume":"26","author":"P Zhou","year":"2014","unstructured":"Zhou P, Huang G, Zhao Y, Zhong D, Xu Z, Zeng Y, Zhang Y, Li S, He F. MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells. Cell Signal. 2014;26(6):1347\u201354.","journal-title":"Cell Signal"},{"key":"3907_CR18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12885-015-1562-9","volume":"15","author":"A Drakaki","year":"2015","unstructured":"Drakaki A, Hatziapostolou M, Polytarchou C, Vorvis C, Poultsides GA, Souglakos J, Georgoulias V, Iliopoulos D. Functional MicroRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway. BMC Cancer. 2015;15:542.","journal-title":"BMC Cancer"},{"key":"3907_CR19","doi-asserted-by":"publisher","first-page":"45195","DOI":"10.1038\/srep45195","volume":"7","author":"Y Zhen","year":"2017","unstructured":"Zhen Y, Xinghui Z, Chao W, Yi Z, Jinwen C, Ruifang G, Chao Z, Min Z, Chunlei G, Yan F, et al. Several MicroRNAs could predict survival in patients with hepatitis B-related liver cancer. Sci Rep. 2017;7:45195.","journal-title":"Sci Rep"},{"key":"3907_CR20","doi-asserted-by":"crossref","unstructured":"Abdel Wahab AHA, Hussein MM, Shouman SA, Fouad D, Kobaisi MH, El Habit O. Role of let7-g and miR-221 level as potential predictors for overall survival of hepatocellular carcinoma patients. Arab J Gastroenterol 2022.","DOI":"10.1016\/j.ajg.2022.03.001"},{"issue":"10","key":"3907_CR21","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/cas.13336","volume":"108","author":"N Maishi","year":"2017","unstructured":"Maishi N, Hida K. Tumor endothelial cells accelerate tumor metastasis. Cancer Sci. 2017;108(10):1921\u20136.","journal-title":"Cancer Sci"},{"key":"3907_CR22","doi-asserted-by":"crossref","unstructured":"Mohr T, Katz S, Paulitschke V, Aizarani N, Tolios A. Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of Tumour Endothelial Cells Identifies Several Tumour-Associated Modules and Potential Therapeutic Targets in Hepatocellular Carcinoma. Cancers 2021, 13(8).","DOI":"10.3390\/cancers13081768"},{"key":"3907_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-0716-2217-9_5","volume":"2475","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Du X, Jiang W, Qiu Y. Measurement of VEGF content in exosomes and subsequent tumor tubulogenesis and in vivo angiogenesis functional assays. Methods Mol Biology (Clifton NJ). 2022;2475:79\u201396.","journal-title":"Methods Mol Biology (Clifton NJ)"},{"issue":"3","key":"3907_CR24","first-page":"213","volume":"37","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Shen J, Jiang W, Yang Y, Liu X, Zeng Y. Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells. Histol Histopathol. 2022;37(3):213\u201325.","journal-title":"Histol Histopathol"},{"issue":"11","key":"3907_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41419-018-1134-4","volume":"9","author":"S Yang","year":"2018","unstructured":"Yang S, Yang C, Yu F, Ding W, Hu Y, Cheng F, Zhang F, Guan B, Wang X, Lu L, et al. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1\/STAT3\/VEGF-A pathway. Cell Death Dis. 2018;9(11):1105.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3907_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12951-024-02902-w","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li X, Dai Y, Han Y, Wei X, Wei G, Chen W, Kong S, He Y, Liu H, et al. Neutrophil N1 polarization induced by cardiomyocyte-derived extracellular vesicle miR-9-5p aggravates myocardial ischemia\/reperfusion injury. J Nanobiotechnol. 2024;22(1):632.","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"3907_CR27","doi-asserted-by":"publisher","first-page":"e0209050","DOI":"10.1371\/journal.pone.0209050","volume":"13","author":"R Matsushima-Nishiwaki","year":"2018","unstructured":"Matsushima-Nishiwaki R, Yamada N, Fukuchi K, Kozawa O. Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2. PLoS ONE. 2018;13(12):e0209050.","journal-title":"PLoS ONE"},{"issue":"11","key":"3907_CR28","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.celrep.2019.11.036","volume":"29","author":"VA Balaji Ragunathrao","year":"2019","unstructured":"Balaji Ragunathrao VA, Anwar M, Akhter MZ, Chavez A, Mao Y, Natarajan V, Lakshmikanthan S, Chrzanowska-Wodnicka M, Dudek AZ, Claesson-Welsh L, et al. Sphingosine-1-Phosphate receptor 1 activity promotes tumor growth by amplifying VEGF-VEGFR2 angiogenic signaling. Cell Rep. 2019;29(11):3472\u2013e34873474.","journal-title":"Cell Rep"},{"key":"3907_CR29","doi-asserted-by":"publisher","first-page":"154068","DOI":"10.1016\/j.phymed.2022.154068","volume":"100","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wu H, Gui BJ, Liu J, Rong GX, Deng R, Bu YH, Zhang H. Geniposide alleviates VEGF-induced angiogenesis by inhibiting VEGFR2\/PKC\/ERK1\/2-mediated SphK1 translocation. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2022;100:154068.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"key":"3907_CR30","doi-asserted-by":"publisher","first-page":"1431211","DOI":"10.3389\/fimmu.2024.1431211","volume":"15","author":"G Du","year":"2024","unstructured":"Du G, Dou C, Sun P, Wang S, Liu J, Ma L. Regulatory T cells and immune escape in HCC: Understanding the tumor microenvironment and advancing CAR-T cell therapy. Front Immunol. 2024;15:1431211.","journal-title":"Front Immunol"},{"issue":"Pt 2","key":"3907_CR31","doi-asserted-by":"publisher","first-page":"113482","DOI":"10.1016\/j.intimp.2024.113482","volume":"143","author":"H Tian","year":"2024","unstructured":"Tian H, Wang W, Liang S, Ding J, Hua D. From darkness to light: targeting CAFs as a new potential strategy for cancer treatment. Int Immunopharmacol. 2024;143(Pt 2):113482.","journal-title":"Int Immunopharmacol"},{"issue":"28","key":"3907_CR32","doi-asserted-by":"publisher","first-page":"e2301166","DOI":"10.1002\/advs.202301166","volume":"10","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhang Q, Teng D, Guo M, Tang K, Wang Z, Wei X, Lin L, Zhang X, Wang X, et al. FGF9 recruits \u03b2-Catenin to increase hepatic ECM synthesis and promote NASH-Driven HCC. Adv Sci (Weinh). 2023;10(28):e2301166.","journal-title":"Adv Sci (Weinh)"},{"issue":"26","key":"3907_CR33","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/JCO.20.00808","volume":"38","author":"RS Finn","year":"2020","unstructured":"Finn RS, Ikeda M, Zhu AX, Sung MW, Baron AD, Kudo M, Okusaka T, Kobayashi M, Kumada H, Kaneko S, et al. Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma. J Clin Oncol. 2020;38(26):2960\u201370.","journal-title":"J Clin Oncol"},{"key":"3907_CR34","doi-asserted-by":"crossref","unstructured":"Xia Y, Tang W, Qian X, Li X, Cheng F, Wang K, Zhang F, Zhang C, Li D, Song J et al. Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial. J Immunother Cancer 2022, 10(4).","DOI":"10.1136\/jitc-2022-004656"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03907-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:01:54Z","timestamp":1757246514000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03907-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3907"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03907-7","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was endorsed by the Ethics Committee of for Medical Research and New Medical Technology of Sichuan Cancer Hospital (SCCHEC-02-2024-068). Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}